Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
HBC announces the publication of its head-to-head clinical trial results with its patented, full spectrum omegas brand, OmeGo®. The trial showed that OmeGo® increased the Omega 3 Index (O3I) by over...
Read MoreThe Board of Directors of Hofseth BioCare ASA ("HBC") has approved the financial statements for 2025, and HBC has today published the Annual Report and Sustainability Report for 2025. In October 2025,...
Read More